PLUS THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Plus Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Plus Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 5.9M shares, a 30.4% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.9M +1.37M +30.4% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 5.7M +2.82M +98.1% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 4.26M -31.9M -88.2% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 4.44M +2.2M +98.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 4.52M -28M -86.1% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 2.88M -19.6M -87.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 36.1M +13.9M +62.7% Mar 31, 2023 10-Q 2023-04-20
Q4 2022 2.24M -13.3M -85.6% Dec 31, 2022 10-K 2024-03-05
Q3 2022 32.6M +17.2M +112% Sep 30, 2022 10-Q 2022-10-20
Q2 2022 22.5M +10.4M +85.9% Jun 30, 2022 10-Q 2022-07-21
Q1 2022 22.2M +12M +118% Mar 31, 2022 10-Q 2022-04-21
Q4 2021 15.5M +8.76M +130% Dec 31, 2021 10-K 2023-02-23
Q3 2021 15.4M +10.8M +235% Sep 30, 2021 10-Q 2021-10-21
Q2 2021 12.1M +7.81M +183% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 10.2M +6.3M +162% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 6.75M +2.87M +73.9% Dec 31, 2020 10-K 2022-02-24
Q3 2020 4.59M +1.75M +61.6% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 4.27M +3.98M +1341% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 3.88M +3.44M +786% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 3.88M +3.58M +1208% Dec 31, 2019 10-K 2021-02-22
Q3 2019 2.84M -8.85M -75.7% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 297K -5.88M -95.2% Jun 30, 2019 10-Q 2019-08-15
Q1 2019 438K -61.2M -99.3% Mar 31, 2019 8-K 2019-09-10
Q4 2018 297K +181K +156% Dec 31, 2018 10-K 2020-03-30
Q3 2018 11.7M -23M -66.3% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 6.18M -27.2M -81.5% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 61.6M +37.8M +159% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 116K -21.6M -99.5% Dec 31, 2017 8-K 2019-09-10
Q3 2017 34.7M +14.2M +69.4% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 33.3M +12.8M +62.6% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 23.8M -176M -88.1% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 21.7M +8.7M +66.9% Dec 31, 2016 10-K 2018-03-09
Q3 2016 20.5M -138M -87.1% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 20.5M -130M -86.4% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 200M +85.9M +75.3% Mar 31, 2016 10-Q 2016-11-09
Q4 2015 13M -86.3M -86.9% Dec 31, 2015 10-K 2017-03-24
Q3 2015 158M +74.9M +89.6% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 151M +71.4M +89.8% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 114M +38.6M +51.2% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 99.3M +28M +39.3% Dec 31, 2014 10-K 2016-03-11
Q3 2014 83.6M +16.3M +24.2% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 79.5M +12.3M +18.3% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 75.5M +8.29M +12.3% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 71.3M +5.39M +8.18% Dec 31, 2013 10-K 2015-03-16
Q3 2013 67.3M +10.7M +18.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 67.2M +8.53M +14.5% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 67.2M +8.74M +15% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 65.9M +9.32M +16.5% Dec 31, 2012 10-K 2014-03-14
Q3 2012 56.6M +1.76M +3.21% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 58.7M +6.24M +11.9% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 58.4M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 56.6M +4.64M +8.93% Dec 31, 2011 10-K 2013-03-15
Q3 2011 54.8M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 52.5M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 52M Dec 31, 2010 10-K/A 2012-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.